Jagat Narula MD, PhD, MACC is Executive Vice President & Chief Academic Officer at the University of Texas Health Sciences Center, and K. Lance Gould Distinguished University Chair for Coronary Pathophysiology at McGovern Medical School, Houston, Texas.
Dr. Narula after completing his clinical fellowship training Cardiology and PhD in Cardiovascular Immunology from the All India Institute of Medical Sciences, Delhi, relocated to Massachusetts General Hospital and Harvard Medical School in 1989. In Boston, he completed cardiology, heart failure & transplantation, and nuclear cardiology fellowships and joined the Cardiology faculty. In 1997, he moved to Hahnemann University School of Medicine, Philadelphia, where he was Thomas J. Vischer Professor of Medicine, Chief of the Division of Cardiology, Vice-Chairman of the department of Internal Medicine, and Director of Heart Failure & Transplantation Center. In 2003, he joined University of California, Irvine School of Medicine as Chief of the Division of Cardiology, Associate Dean for Research, and Director of the Cardiovascular Center of the UC Irvine’s Douglas Hospital. He was also the Director of Memorial Heart & Vascular Institute- Long Beach Memorial Hospital, and Medical Director of the UC Irvine’s Edwards Lifesciences Center for Advanced Cardiovascular Technology. Dr. Narula moved to Mount Sinai in March 2011, where he was the Philip J. & Harriet L. Goodhart Chair of Cardiovascular Medicine at the Zena & Michael A. Wiener Cardiovascular Institute of the Icahn School of Medicine, Chief of the Division of Cardiology of Mount Sinai Morningside, Director of Cardiovascular Imaging Program for the Mount Sinai Health System, and Associate Dean for Global Health at School of Medicine. He relocated to UTHealth, Houston, Texas, in January 2023.
Dr. Narula is an established investigator with a focus on translational research from bench to bedside, and population sciences and global cardiovascular health. His major contributions to the field of cardiovascular medicine have included (1) the description of the phenomenon of heart muscle cell suicide (apoptosis) in heart failure, (2) identification of vulnerability of atherosclerotic plaques to rupture causing acute coronary syndromes, and (3) developing recommendations for cardiovascular disease prevention in low- and middle-income countries. He has invoked all invasive and noninvasive imaging modalities including molecular imaging for the study of myocardial disorders and plaque characteristics. His research has been funded, in part, by the grants from National Institutes of Health. He is considered to be a true translationist and a rare investigator who has the distinction of publishing in the best basic science and the best clinical medicine journals including Science, Nature Medicine, PNAS, New England Journal of Medicine and Lancet. He is actively involved in population-based heart attack prevention programs such as HAPPY [Heart Attack Prevention Program for You], being run in many countries.
English 
Spanish